Nidanilimab (Nadunolimab), CAS [[2171061-85-9]]

Produktübersicht

• Artikelname: Nidanilimab (Nadunolimab), CAS [[2171061-85-9]]
• Artikelnummer: MCE-HY-P99379
• Hersteller Artikelnummer: HY-P99379
• Alternativnummer: MCE-HY-P99379-5MG,MCE-HY-P99379-1MG,MCE-HY-P99379-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: CAN04, Anti-IL-1RAP/IL-1R3 Reference Antibody (nidanilimab)

Produktbeschreibung

Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody with a Kd value of 1.10 pM. Nidanilimab blocks IL1alpha and IL1beta signaling and stimulates the immune system to destroy tumour cells. Nidanilimab can be used in research of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) [1][2].

Produkteigenschaften

• Molekulargewicht: (144.3 kDa)
• Reinheit: 99.90
• CAS Nummer: [2171061-85-9]
• Target-Kategorie: Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies